TRIM33 and non-small cell lung carcinoma: Numerous studies have demonstrated that TIF1γ can inhibit tumor growth, TGF-β-induced epithelial mesenchymal transition and metastasis, and that its expression is reduced in non-small-cell lung cancer and breast cancer [Figure 3; (21, 22, 35)].